Case Report: Decentralized trial of tolerability-adapted exercise therapy after severe Covid-19.
Saved in:
| Title: | Case Report: Decentralized trial of tolerability-adapted exercise therapy after severe Covid-19. |
|---|---|
| Authors: | Scott JM; Department of Medicine, Memorial Sloan Kettering Cancer Center (MSK), New York, NY, United States.; Department of Medicine, Weill Cornell Medical College, New York, NY, United States., Qiu Z; Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA, United States.; Department of Human Genetics, University of California, Los Angeles, Los Angeles, CA, United States., Rahman J; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, United States., Moskowitz CS; Department of Medicine, Memorial Sloan Kettering Cancer Center (MSK), New York, NY, United States., Michalski MG; Department of Medicine, Memorial Sloan Kettering Cancer Center (MSK), New York, NY, United States., Lehman S; Department of Medicine, Memorial Sloan Kettering Cancer Center (MSK), New York, NY, United States., Lee CP; Department of Medicine, Memorial Sloan Kettering Cancer Center (MSK), New York, NY, United States., Harrison J; Department of Medicine, Memorial Sloan Kettering Cancer Center (MSK), New York, NY, United States., Yu AF; Department of Medicine, Memorial Sloan Kettering Cancer Center (MSK), New York, NY, United States.; Department of Medicine, Weill Cornell Medical College, New York, NY, United States., Marouf A; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, United States.; Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, United States., Vardhana S; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, United States.; Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, United States., Boutros PC; Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA, United States.; Department of Human Genetics, University of California, Los Angeles, Los Angeles, CA, United States.; Department of Urology, University of California, Los Angeles, CA, United States.; Institute for Precision Health, University of California, Los Angeles, CA, United States., Jones LW; Department of Medicine, Memorial Sloan Kettering Cancer Center (MSK), New York, NY, United States.; Department of Medicine, Weill Cornell Medical College, New York, NY, United States. |
| Source: | Frontiers in immunology [Front Immunol] 2025 Apr 03; Vol. 16, pp. 1529385. Date of Electronic Publication: 2025 Apr 03 (Print Publication: 2025). |
| Publication Type: | Clinical Trial, Phase I; Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1664-3224 |
|---|---|
| DOI: | 10.3389/fimmu.2025.1529385 |
